Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data

Beta-adrenoblockers in coronary heart disease patients. Evidencebased medicine data

High effectiveness and safety of beta-adrenoblockers (BB) in patients with coronary heart disease (CHD) have been proven by manifold clinical trials. BB are effective and safe, provided dose regimen is correct and contraindications are taken into account. BB significantly reduce total mortality and...

Full description

Bibliographic Details
Main Authors:	A. E. Radzevich, A. G. Evdokimova, A. Yu. Konyakhin, V. V. Popov
Format:	Article
Language:	Russian
Published:	«SILICEA-POLIGRAF» LLC 1970-01-01
Series:	Кардиоваскулярная терапия и профилактика
Subjects:	ишемическая болезнь сердца внезапная сердечная смерть β-адреноблокаторы
Online Access:	https://cardiovascular.elpub.ru/jour/article/view/1505

Similar Items

Modern views on myocardial electric instability correction and prognosis improvement in coronary heart disease patients
by: V. V. Popov, et al.
Published: (2007-06-01)

Stable coronary heart disease treatment: focus on beta-adrenoblockers
by: V. I. Makolkin
Published: (2008-12-01)

Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians
by: I. A. Libov, et al.
Published: (2009-04-01)

Modern therapeutic potential of super-selective β<sup>1</sup>-adrenoblocker nebivolol
by: V. I. Makolkin, et al.
Published: (1970-01-01)

Механизмы возникновения внезапной сердечной смерти
by: Данила Александрович Степанов, et al.
Published: (2019-03-01)

МЕТОДЫ СТАНДАРТИЗАЦИИ В ОПРЕДЕЛЕНИИ МЕСТА ВНЕЗАПНОЙ КОРОНАРНОЙ СМЕРТИ СРЕДИ ПРОЧИХ ФОРМ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА
Published: (2006-12-01)

Omega-3 index of erythrocytes and predictors of sudden cardiac death in patients with coronary heart disease and ventricular arrhythmias
by: E. M. Gavva, et al.
Published: (2012-08-01)

Could secondary prevention of coronary heart disease be more effective?
by: V. I. Makolkin
Published: (2010-02-01)

Medical support of children’s sports: Topical problems
by: L. A. Balykova, et al.
Published: (2017-05-01)

Differential beta-adrenoblocker therapy in chronic heart failure
by: S. N. Tereshchenko, et al.
Published: (1970-01-01)

NUCLEAR IMAGING IN SUDDEN CARDIAC DEATH RISK ASSESSMENT
by: A. A. Ansheles, et al.
Published: (2018-04-01)

Beta-adrenoblocker in heart failure: bisoprolol role
by: Yu. V. Lukina, et al.
Published: (1970-01-01)

Pharmacokinetics and pharmacodynamics of a β-adrenoblocker bisoprolol: from mechanisms of action to clinical features
by: O. D. Ostroumova, et al.
Published: (2011-06-01)

ROLE OF MEDICATIONS WITH NEGATIVE CHRONOTROPIC EFFECT IN THE TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE AND HEART FAILURE
by: M. G. Glezer, et al.
Published: (2013-10-01)

Взаимосвязь малых аномалий развития соединительной ткани сердца с риском внезапной сердечной смерти
by: V. A. Kuznetsov, et al.
Published: (2018-04-01)

Bisoprolol effectiveness in arterial hypertension and coronary heart disease
by: O. D. Ostroumova, et al.
Published: (1970-01-01)

Clinical efficacy of nebivolol and metoprolol in complex treatment of patients with coronary heart disease and II-III functional class chronic heart failure
by: A. G. Evdokimova, et al.
Published: (2005-04-01)

Non-compaction cardiomyopathy: clinical forms, outcomes and survival in a cohort of belarusian patients
by: S. M. Komissarova, et al.
Published: (2022-05-01)

ABCA1 gene promoter methylation and sudden cardiac death
by: A. A. Ivanova, et al.
Published: (2021-01-01)

Molecular genetic aspects of sudden cardiac death: a literature review
by: A. A. Ivanova, et al.
Published: (2018-12-01)

Sudden cardiac death and antipsychotic medications: literature review
by: V. P. Volkov
Published: (2012-10-01)

RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY
by: M. L. Maximov
Published: (2015-12-01)

The non-compact left ventricle cardiomyopathy: clinical features and diagnostic capabilities
by: E. A. Mershina, et al.
Published: (2015-12-01)

Optimizatsiya lecheniya patsientov s sochetannymi formami arterial'noy gipertonii i ishemicheskoy bolezni serdtsa
by: E G Volkova
Published: (2005-06-01)

Cardioselective beta-adrenoblocker bisoprolol in treating hypertensive patients with heart failure
by: A. N. Britov
Published: (2005-06-01)

Physical rehabilitation and endothelial dysfunction in coronary heart disease
by: V. A. Margazin, et al.
Published: (2006-02-01)

A COMPLEX ASSESSMENT OF COMBINATION DRUG THERAPY IN CARDIOVASCULAR COMORBIDITY
by: Yu. V. Luneva, et al.
Published: (2016-08-01)

PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)
by: N. V. Melnik
Published: (2018-01-01)

Differential approach in selecting beta-adrenoblocker therapy for patients with chronic heart failure and anaemia
by: T. M. Uskach, et al.
Published: (2012-04-01)

Danon’s disease as a cause of hypertrophic cardiomyopathy
by: I. V. Leontyeva, et al.
Published: (2016-03-01)

Подкожные кардиовертеры-дефибрилляторы в сравнении с трансвенозными: 6-месячное наблюдение
by: А.В. Верещагина, et al.
Published: (2023-03-01)

NOVEL COMBINATION OF THE ANGIOTENSIN CONVERTING ENZYME INHIBITOR PERINDOPRIL AND HIGHLY SELECTIVE β-ADRENOBLOCKER BISOPROLOL: PRIME AMONG THE EQUAL
by: O. D. Ostroumova, et al.
Published: (2018-06-01)

Prognostic role of metabolic risk factors (hyperhomocysteinemia) in the development of chronic heart failure
by: Е. Н. Березикова, et al.
Published: (2015-10-01)

Beta-adrenoblockers in clinical practice: is there any difference?
by: D. V. Nebieridze, et al.
Published: (2007-06-01)

СИНДРОМ БРУГАДА
by: Виктор Николаевич Федорец, et al.
Published: (2022-01-01)

HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE
by: V. P. Lupanov
Published: (2015-12-01)

Are SIDS, SUDC and SUDEP the different masks of the same great mystery?
by: L. A. Kravtsova
Published: (2021-12-01)

Chronic heart failure in out-patient practice: aetiology issues
by: S. M. Bogdanova, et al.
Published: (2008-08-01)

Implantable cardioverter-defibrillators in sudden cardiac death prevention: guidelines and clinical practice (literature review)
by: I. V. Talibullin, et al.
Published: (2022-04-01)

JUSTIFICATION OF A SYSTEMIC APPROACH IN THE SUDDEN CARDIAC DEATH PREVENTION: A POSSIBLE SOLUTION TO THE PROBLEM OF EXCESSIVE MORTALITY IN RUSSIA (LITERATURE REVIEW) PART I. CARDIOVASCULAR ASPECTS OF EXCESSIVE MORALITY IN RUSSIA: THE STATE OF THE PROBLEM AND POTENTIAL FOR PREVENTION
by: A. S. Dimov, et al.
Published: (2013-04-01)